These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21117496)

  • 21. Does neuropeptide Y (NPY) mediate the effects of psychotropic drugs?
    Obuchowicz E; Krysiak R; Herman ZS
    Neurosci Biobehav Rev; 2004 Oct; 28(6):595-610. PubMed ID: 15527865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The current extent of biological therapy of mental disorders. I].
    Predescu V; Alexandrescu L; Ciurez T
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1980; 25(3):161-83. PubMed ID: 6110231
    [No Abstract]   [Full Text] [Related]  

  • 23. Psychotropic drug use during pregnancy: weighing the risks.
    Cohen LS; Rosenbaum JF
    J Clin Psychiatry; 1998; 59 Suppl 2():18-28. PubMed ID: 9559756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of nicotine nasal spray on cognitive function in schizophrenia.
    Smith RC; Warner-Cohen J; Matute M; Butler E; Kelly E; Vaidhyanathaswamy S; Khan A
    Neuropsychopharmacology; 2006 Mar; 31(3):637-43. PubMed ID: 16160711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Somatic side effects of psychopharmaceuticals].
    Schmidmeier R
    MMW Fortschr Med; 2006 Nov; 148(46):27-9. PubMed ID: 17615784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nicotine dependence and psychiatric disorders.
    Salín-Pascual RJ; Alcocer-Castillejos NV; Alejo-Galarza G
    Rev Invest Clin; 2003; 55(6):677-93. PubMed ID: 15011738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nicotine and cognitive efficiency in alcoholics and illicit stimulant abusers: implications of smoking cessation for substance users in treatment.
    Ceballos NA; Tivis R; Lawton-Craddock A; Nixond SJ
    Subst Use Misuse; 2006; 41(3):265-81. PubMed ID: 16467005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: comparison with sertraline.
    Andreasen JT; Henningsen K; Bate S; Christiansen S; Wiborg O
    J Psychopharmacol; 2011 Aug; 25(8):1134-41. PubMed ID: 21169388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1976 Oct; 18(22):89-96. PubMed ID: 10519
    [No Abstract]   [Full Text] [Related]  

  • 32. Development of nicotinic drug therapy for cognitive disorders.
    Levin ED; Rezvani AH
    Eur J Pharmacol; 2000 Mar; 393(1-3):141-6. PubMed ID: 10771007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the trail of a cognitive enhancer for the treatment of schizophrenia.
    Stip E; Chouinard S; Boulay LJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):219-32. PubMed ID: 15694228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive Effects of Nicotine: Recent Progress.
    Valentine G; Sofuoglu M
    Curr Neuropharmacol; 2018; 16(4):403-414. PubMed ID: 29110618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Modern pharmacotherapy in psychiatry].
    Vinar O
    Psychiatr Neurol Med Psychol Beih; 1966; 4-5():155-71. PubMed ID: 4157249
    [No Abstract]   [Full Text] [Related]  

  • 36. [How should mentally handicapped adults with depressive disorders be treated psychopharmacologically?].
    Meins W
    Nervenarzt; 1996 Mar; 67(3):216-8. PubMed ID: 8901279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective and neurotoxic effects of nicotine.
    Ferrea S; Winterer G
    Pharmacopsychiatry; 2009 Nov; 42(6):255-65. PubMed ID: 19924585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Psychotropic drugs].
    Müller-Spahn F
    Ther Umsch; 1999 Dec; 56(12):719-25. PubMed ID: 10638279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diversity and variability of the effects of nicotine on different cortical regions of the brain - therapeutic and toxicological implications.
    Toledano A; Alvarez MI; Toledano-Díaz A
    Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):180-206. PubMed ID: 20528766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nicotine-haloperidol interactions and cognitive performance in schizophrenics.
    Levin ED; Wilson W; Rose JE; McEvoy J
    Neuropsychopharmacology; 1996 Nov; 15(5):429-36. PubMed ID: 8914115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.